Neuropharmacology & Neurotherapeutics
SSRIs
Oct. 21, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Adherence to methodological quality criteria according to the consolidated standards of reporting trial statement (Altman et al 2001) of published controlled trials (references indicated between parentheses in table first row) with glatiramer acetate, mitoxantrone, or natalizumab in multiple sclerosis. (Contributed by Dr. Luca Durelli.)